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Lampiran 3  
 
Frequency Table (Pasien Ikterus) 
 
Kreatinin 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
normal 8 13.8 13.8 13.8 
meningkat 50 86.2 86.2 100.0 
Total 58 100.0 100.0  
 
Ureum 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
normal 5 8.6 8.6 8.6 
meningkat 53 91.4 91.4 100.0 
Total 58 100.0 100.0  
 
Kalium 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
menurun 23 39.7 39.7 39.7 
normal 25 43.1 43.1 82.8 
meningkat 10 17.2 17.2 100.0 




















Kreatinin * Ureum Crosstabulation 




Count 4 4 8 
% within Kreatinin 50.0% 50.0% 100.0% 
% within Ureum 80.0% 7.5% 13.8% 
meningkat 
Count 1 49 50 
% within Kreatinin 2.0% 98.0% 100.0% 
% within Ureum 20.0% 92.5% 86.2% 
Total 
Count 5 53 58 
% within Kreatinin 8.6% 91.4% 100.0% 
% within Ureum 100.0% 100.0% 100.0% 
 
pulmo 1 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak lengkap 37 63.8 63.8 63.8 
normal 11 19.0 19.0 82.8 
ARDS 5 8.6 8.6 91.4 
Acute Lung Injury 5 8.6 8.6 100.0 
Total 58 100.0 100.0  
 
Hemoptoe 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
normal 53 91.4 91.4 91.4 
tidak normal 5 8.6 8.6 100.0 










 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak lengkap 32 55.2 55.2 55.2 
normal 13 22.4 22.4 77.6 
bronkopneumoni 11 19.0 19.0 96.6 
pneumoni 2 3.4 3.4 100.0 
Total 58 100.0 100.0  
 
iskemik anterior 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak lengkap 21 36.2 36.2 36.2 
tidak 34 58.6 58.6 94.8 
ya 3 5.2 5.2 100.0 
Total 58 100.0 100.0  
 
st elevasi 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak lengkap 21 36.2 36.2 36.2 
tidak 35 60.3 60.3 96.6 
ya 2 3.4 3.4 100.0 
Total 58 100.0 100.0  
 
st depresi 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak lengkap 21 36.2 36.2 36.2 
tidak 36 62.1 62.1 98.3 
ya 1 1.7 1.7 100.0 









 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak lengkap 21 36.2 36.2 36.2 
tidak 36 62.1 62.1 98.3 
ya 1 1.7 1.7 100.0 
Total 58 100.0 100.0  
 
CHF NYHA III 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak lengkap 21 36.2 36.2 36.2 
tidak 36 62.1 62.1 98.3 
ya 1 1.7 1.7 100.0 
Total 58 100.0 100.0  
 
sinus takikardi 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak lengkap 21 36.2 36.2 36.2 
tidak 26 44.8 44.8 81.0 
ya 11 19.0 19.0 100.0 
Total 58 100.0 100.0  
 
AV block 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak lengkap 21 36.2 36.2 36.2 
tidak 36 62.1 62.1 98.3 
ya 1 1.7 1.7 100.0 






AF rapid respond 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak lengkap 21 36.2 36.2 36.2 
tidak 35 60.3 60.3 96.6 
ya 2 3.4 3.4 100.0 
Total 58 100.0 100.0  
 
RBBB komplit 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak lengkap 21 36.2 36.2 36.2 
tidak 36 62.1 62.1 98.3 
ya 1 1.7 1.7 100.0 
Total 58 100.0 100.0  
 
LV strain 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak lengkap 21 36.2 36.2 36.2 
tidak 36 62.1 62.1 98.3 
ya 1 1.7 1.7 100.0 
Total 58 100.0 100.0  
 
Total Bilirubin 
 Frequency Percent Valid Percent Cumulative 
Percent 












 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
normal 9 15.5 15.5 15.5 
meningkat 49 84.5 84.5 100.0 
Total 58 100.0 100.0  
 
SGPT 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
menurun 4 6.9 6.9 6.9 
normal 23 39.7 39.7 46.6 
meningkat 31 53.4 53.4 100.0 
Total 58 100.0 100.0  
 
Keterlibatan Organ Hepar 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid ya 58 100.0 100.0 100.0 
 
Keterlibatan Organ Paru 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak 2 3.4 3.4 3.4 
ya 19 32.8 32.8 36.2 
tidak lengkap 37 63.8 63.8 100.0 







Keterlibatan Organ Jantung 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak 18 31.0 31.0 31.0 
ya 19 32.8 32.8 63.8 
tidak lengkap 21 36.2 36.2 100.0 
Total 58 100.0 100.0  
 
Keterlibatan Organ Ginjal 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak 1 1.7 1.7 1.7 
ya 57 98.3 98.3 100.0 




 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak 51 87.9 87.9 87.9 
ya 7 12.1 12.1 100.0 
Total 58 100.0 100.0  
 
Keterlibatan Jantung,paru,ginjal 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak 51 87.9 87.9 87.9 
ya 7 12.1 12.1 100.0 









 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak 51 87.9 87.9 87.9 
ya 7 12.1 12.1 100.0 
Total 58 100.0 100.0  
 
Keterlibatan Jantung,ginjal,hepar 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak 39 67.2 67.2 67.2 
ya 19 32.8 32.8 100.0 
Total 58 100.0 100.0  
 
Keterlibatan paru,ginjal,hepar 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak 39 67.2 67.2 67.2 
ya 19 32.8 32.8 100.0 
Total 58 100.0 100.0  
 
Keterlibatan Jantung,paru 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak 51 87.9 87.9 87.9 
ya 7 12.1 12.1 100.0 












 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak 39 67.2 67.2 67.2 
ya 19 32.8 32.8 100.0 
Total 58 100.0 100.0  
 
Keterlibatan Jantung,hepar 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak 39 67.2 67.2 67.2 
ya 19 32.8 32.8 100.0 
Total 58 100.0 100.0  
 
Keterlibatan paru,hepar 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak 39 67.2 67.2 67.2 
ya 19 32.8 32.8 100.0 
Total 58 100.0 100.0  
 
Keterlibatan ginjal,hepar 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak 1 1.7 1.7 1.7 
ya 57 98.3 98.3 100.0 










 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak 39 67.2 67.2 67.2 
ya 19 32.8 32.8 100.0 
Total 58 100.0 100.0  
 
Trombosit + kreatinin 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
Trombositopeni 3 5.2 5.2 5.2 
trombositopeni + 
peningkatan kreatinin 
38 65.5 65.5 70.7 
Normal 4 6.9 6.9 77.6 
peningkatan kreatinin 11 19.0 19.0 96.6 
peningkatan trombosit 1 1.7 1.7 98.3 
peningkatan trombosit + 
peningkatan kreatinin 
1 1.7 1.7 100.0 
Total 58 100.0 100.0  
 
 
Frequency Table (Pasien anikterik) 
 
Kreatinin 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
normal 12 46.2 46.2 46.2 
meningkat 14 53.8 53.8 100.0 










 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
normal 11 42.3 42.3 42.3 
meningkat 15 57.7 57.7 100.0 
Total 26 100.0 100.0  
 
Kalium 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
menurun 11 42.3 42.3 42.3 
normal 10 38.5 38.5 80.8 
meningkat 5 19.2 19.2 100.0 
Total 26 100.0 100.0  
 
Kreatinin * Ureum Crosstabulation 




Count 11 1 12 
% within Kreatinin 91.7% 8.3% 100.0% 
% within Ureum 100.0% 6.7% 46.2% 
meningkat 
Count 0 14 14 
% within Kreatinin 0.0% 100.0% 100.0% 
% within Ureum 0.0% 93.3% 53.8% 
Total 
Count 11 15 26 
% within Kreatinin 42.3% 57.7% 100.0% 










 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak lengkap 18 69.2 69.2 69.2 
normal 6 23.1 23.1 92.3 
ARDS 1 3.8 3.8 96.2 
Acute Lung Injury 1 3.8 3.8 100.0 
Total 26 100.0 100.0  
 
hemoptoe 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
normal 25 96.2 96.2 96.2 
tidak normal 1 3.8 3.8 100.0 
Total 26 100.0 100.0  
 
bronkopneumoni_pneumoni 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak lengkap 15 57.7 57.7 57.7 
normal 6 23.1 23.1 80.8 
bronkopneumoni 5 19.2 19.2 100.0 
Total 26 100.0 100.0  
 
iskemik anterior 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak lengkap 8 30.8 30.8 30.8 
tidak 17 65.4 65.4 96.2 
ya 1 3.8 3.8 100.0 






 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak lengkap 8 30.8 30.8 30.8 
tidak 18 69.2 69.2 100.0 
Total 26 100.0 100.0  
 
st depresi 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak lengkap 8 30.8 30.8 30.8 
tidak 18 69.2 69.2 100.0 
Total 26 100.0 100.0  
 
IHD 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak lengkap 8 30.8 30.8 30.8 
tidak 18 69.2 69.2 100.0 
Total 26 100.0 100.0  
 
CHF NYHA III 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak lengkap 8 30.8 30.8 30.8 
tidak 18 69.2 69.2 100.0 
Total 26 100.0 100.0  
 
sinus takikardi 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak lengkap 8 30.8 30.8 30.8 
tidak 13 50.0 50.0 80.8 
ya 5 19.2 19.2 100.0 






 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak lengkap 8 30.8 30.8 30.8 
tidak 18 69.2 69.2 100.0 
Total 26 100.0 100.0  
 
AF rapid respond 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak lengkap 8 30.8 30.8 30.8 
tidak 18 69.2 69.2 100.0 
Total 26 100.0 100.0  
 
RBBB komplit 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak lengkap 8 30.8 30.8 30.8 
tidak 18 69.2 69.2 100.0 
Total 26 100.0 100.0  
 
LV strain 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak lengkap 8 30.8 30.8 30.8 
tidak 18 69.2 69.2 100.0 
Total 26 100.0 100.0  
 
Total Bilirubin 
 Frequency Percent Valid Percent Cumulative 
Percent 








 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
menurun 1 3.8 3.8 3.8 
normal 11 42.3 42.3 46.2 
meningkat 14 53.8 53.8 100.0 
Total 26 100.0 100.0  
 
SGPT 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
menurun 1 3.8 3.8 3.8 
normal 18 69.2 69.2 73.1 
meningkat 7 26.9 26.9 100.0 
Total 26 100.0 100.0  
 
Keterlibatan Organ Hepar 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak 7 26.9 26.9 26.9 
ya 19 73.1 73.1 100.0 
Total 26 100.0 100.0  
 
Keterlibatan Organ Paru 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
ya 6 23.1 23.1 23.1 
tidak lengkap 20 76.9 76.9 100.0 








Keterlibatan Organ Jantung 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak 12 46.2 46.2 46.2 
ya 6 23.1 23.1 69.2 
tidak lengkap 8 30.8 30.8 100.0 
Total 26 100.0 100.0  
 
Keterlibatan Organ Ginjal 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak 6 23.1 23.1 23.1 
ya 20 76.9 76.9 100.0 
Total 26 100.0 100.0  
 
Keterlibatan hepar,ginjal,paru,jantung 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak 24 92.3 92.3 92.3 
ya 2 7.7 7.7 100.0 
Total 26 100.0 100.0  
 
Keterlibatan jantung,paru,ginjal 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak 24 92.3 92.3 92.3 
ya 2 7.7 7.7 100.0 
Total 26 100.0 100.0  
 
Keterlibatan Jantung,paru,hepar 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak 24 92.3 92.3 92.3 
ya 2 7.7 7.7 100.0 






 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak 22 84.6 84.6 84.6 
ya 4 15.4 15.4 100.0 
Total 26 100.0 100.0  
 
Keterlibatan paru,ginjal,hepar 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak 23 88.5 88.5 88.5 
ya 3 11.5 11.5 100.0 
Total 26 100.0 100.0  
 
Keterlibatan Jantung,paru 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak 24 92.3 92.3 92.3 
ya 2 7.7 7.7 100.0 
Total 26 100.0 100.0  
 
Keterlibatan Jantung,ginjal 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak 22 84.6 84.6 84.6 
ya 4 15.4 15.4 100.0 
Total 26 100.0 100.0  
 
Keterlibatan Jantung,hepar 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak 21 80.8 80.8 80.8 
ya 5 19.2 19.2 100.0 






 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak 22 84.6 84.6 84.6 
ya 4 15.4 15.4 100.0 
Total 26 100.0 100.0  
 
Keterlibatan ginjal,hepar 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak 11 42.3 42.3 42.3 
ya 15 57.7 57.7 100.0 
Total 26 100.0 100.0  
 
Keterlibatan ginjal,paru 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
tidak 21 80.8 80.8 80.8 
ya 5 19.2 19.2 100.0 
Total 26 100.0 100.0  
 
Trombosit + kreatinin 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
trombositopeni 4 15.4 15.4 15.4 
trombositopeni + 
peningkatan kreatinin 
9 34.6 34.6 50.0 
Normal 7 26.9 26.9 76.9 
peningkatan kreatinin 5 19.2 19.2 96.2 
peningkatan trombosit 1 3.8 3.8 100.0 






































































Computed only  f or a 2x2 tablea. 
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2 cells (33.3%) have expected count less than 5. The



























































Nama   : R. Ernandy Aryo Hudoyo 
NIM   : 22010111120011 
Tempat/tanggal lahir : Semarang/ 8 September 1993 
Jenis Kelamin  : Laki-laki 
Alamat  : Perum. Sinar Sawunggaling A2 Semarang 
Nomor Telepon : 024 7460807 
Nomor HP  : 085641140566 
Email    : Nandy.aryo@yahoo.com 
 
Riwayat Pendidikan Formal 
SD  : SD Islam Hidayatullah Semarang   Lulus tahun: 2005 
SMP : SMP Negeri 5 Kota Semarang   Lulus tahun: 2008 
SMA : SMA Negeri 1 Kota Semarang   Lulus tahun: 2011 
 
Keanggotaan Organisasi 
1. Staff Hubungan Luar HIMA KU 2012 
2. Staff KSKI ROHIS KU 2012 
3. Staff Social Art AMSA 2012 
4. Kabid Hubungan Luar HIMA KU 2013 
5. PHW Pengmas ISMKI Wilayah III 2013 
6. Kordep Hubungan Luar HIMA KU 2014 
7. Anggota Paduan Suara Mahasiswa FK UNDIP 2011-2015 
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